Conventional NK cells can produce IL-22 and promote host defense in Klebsiella pneumoniae pneumonia

Journal of Immunology

Volumn 192, Issue 4, 2014, Pages 1778-1786

  Xu, Xin ^a   Weiss, Ido D ^a   Zhang, Hongwei H ^a   Singh, Satya P ^a   Wynn, Thomas A ^a   Wilson, Mark S ^a,b   Farber, Joshua M ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; ANTIGENS, LY; DNA-BINDING PROTEINS; FEMALE; INTERLEUKIN RECEPTOR COMMON GAMMA SUBUNIT; INTERLEUKINS; KILLER CELLS, NATURAL; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; LUNG; LYMPHOCYTE DEPLETION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY B; PNEUMONIA; RECEPTORS, CCR6; SURVIVAL;

EID: 84894288461     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300039     Document Type: Article

References (70)

1. Aujla, S. J., Y. R. Chan, M. Zheng, M. Fei, D. J. Askew, D. A. Pociask, T. A. Reinhart, F. McAllister, J. Edeal, K. Gaus, et al. 2008. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat. Med. 14: 275-281.
2. Ye, P., P. B. Garvey, P. Zhang, S. Nelson, G. Bagby, W. R. Summer, P. Schwarzenberger, J. E. Shellito, and J. K. Kolls. 2001. Interleukin-17 and lung host defense against Klebsiella pneumoniae infection. Am. J. Respir. Cell Mol. Biol. 25: 335-340.
3. Zenewicz, L. A., and R. A. Flavell. 2011. Recent advances in IL-22 biology. Int. Immunol. 23: 159-163.
4. Kudva, A., E. V. Scheller, K. M. Robinson, C. R. Crowe, S. M. Choi, S. R. Slight, S. A. Khader, P. J. Dubin, R. I. Enelow, J. K. Kolls, and J. F. Alcorn. 2011. Influenza A inhibits Th17-mediated host defense against bacterial pneumonia in mice. J. Immunol. 186: 1666-1674.
5. Fernandes, B. F., A. B. Rezende, C. C. Alves, F. M. Teixeira, R. E. Farias, A. P. Ferreira, and H. C. Teixeira. 2010. Splenic autotransplantation restores IL-17 production and antibody response to Streptococcus pneumoniae in splenectomized mice. Transpl. Immunol. 22: 195-197.
6. Happel, K. I., M. Zheng, E. Young, L. J. Quinton, E. Lockhart, A. J. Ramsay, J. E. Shellito, J. R. Schurr, G. J. Bagby, S. Nelson, and J. K. Kolls. 2003. Cutting edge: roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection. J. Immunol. 170: 4432-4436.
7. Hirsch, E. B., and V. H. Tam. 2010. Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrugresistant infection. J. Antimicrob. Chemother. 65: 1119-1125.
8. Bradford, P. A., S. Bratu, C. Urban, M. Visalli, N. Mariano, D. Landman, J. J. Rahal, S. Brooks, S. Cebular, and J. Quale. 2004. Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenemhydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City. Clin. Infect. Dis. 39: 55-60.
9. Gupta, N., B. M. Limbago, J. B. Patel, and A. J. Kallen. 2011. Carbapenemresistant Enterobacteriaceae: epidemiology and prevention. Clin. Infect. Dis. 53: 60-67.
10. Snitkin, E. S., A. M. Zelazny, P. J. Thomas, F. Stock, D. K. Henderson, T. N. Palmore, and J. A. Segre. 2012. Tracking a hospital outbreak of carbapenemresistant Klebsiella pneumoniae with whole-genome sequencing. Sci. Transl. Med. 4: 148ra116.
11. Wolk, K., S. Kunz, K. Asadullah, and R. Sabat. 2002. Cutting edge: immune cells as sources and targets of the IL-10 family members? J. Immunol. 168: 5397-5402.
12. Wolk, K., and R. Sabat. 2006. Interleukin-22: a novel T- and NK-cell derived cytokine that regulates the biology of tissue cells. Cytokine Growth Factor Rev. 17: 367-380.
13. Pestka, S., C. D. Krause, D. Sarkar, M. R. Walter, Y. Shi, and P. B. Fisher. 2004. Interleukin-10 and related cytokines and receptors. Annu. Rev. Immunol. 22: 929-979.
14. Whittington, H. A., L. Armstrong, K. M. Uppington, and A. B. Millar. 2004. Interleukin-22: a potential immunomodulatory molecule in the lung. Am. J. Respir. Cell Mol. Biol. 31: 220-226.
15. Kumar, P., M. S. Thakar, W. Ouyang, and S. Malarkannan. 2013. IL-22 from conventional NK cells is epithelial regenerative and inflammation protective during influenza infection. Mucosal Immunol. 6: 69-82.
16. Zheng, Y., D. M. Danilenko, P. Valdez, I. Kasman, J. Eastham-Anderson, J. Wu, and W. Ouyang. 2007. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445: 648-651.
17. Satoh-Takayama, N., C. A. Vosshenrich, S. Lesjean-Pottier, S. Sawa, M. Lochner, F. Rattis, J. J. Mention, K. Thiam, N. Cerf-Bensussan, O. Mandelboim, et al. 2008. Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity 29: 958-970.
18. Zheng, Y., P. A. Valdez, D. M. Danilenko, Y. Hu, S. M. Sa, Q. Gong, A. R. Abbas, Z. Modrusan, N. Ghilardi, F. J. de Sauvage, and W. Ouyang. 2008. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat. Med. 14: 282-289.
19. Cella, M., A. Fuchs, W. Vermi, F. Facchetti, K. Otero, J. K. Lennerz, J. M. Doherty, J. C. Mills, and M. Colonna. 2009. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 457: 722-725.
20. Hedrick, M. N., A. S. Lonsdorf, A. K. Shirakawa, C. C. Richard Lee, F. Liao, S. P. Singh, H. H. Zhang, A. Grinberg, P. E. Love, S. T. Hwang, and J. M. Farber. 2009. CCR6 is required for IL-23-induced psoriasis-like inflammation in mice. J. Clin. Invest. 119: 2317-2329.
21. Monticelli, L. A., G. F. Sonnenberg, M. C. Abt, T. Alenghat, C. G. Ziegler, T. A. Doering, J. M. Angelosanto, B. J. Laidlaw, C. Y. Yang, T. Sathaliyawala, et al. 2011. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat. Immunol. 12: 1045-1054.
22. Sonnenberg, G. F., L. A. Monticelli, M. M. Elloso, L. A. Fouser, and D. Artis. 2011. CD4(+) lymphoid tissue-inducer cells promote innate immunity in the gut. Immunity 34: 122-134.
23. Spits, H., and J. P. Di Santo. 2011. The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nat. Immunol. 12: 21-27.
24. Orange, J. S., B. Wang, C. Terhorst, and C. A. Biron. 1995. Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J. Exp. Med. 182: 1045-1056.
25. Tay, C. H., E. Szomolanyi-Tsuda, and R. M. Welsh. 1998. Control of infections by NK cells. Curr. Top. Microbiol. Immunol. 230: 193-220.
26. Vankayalapati, R., A. Garg, A. Porgador, D. E. Griffith, P. Klucar, H. Safi, W. M. Girard, D. Cosman, T. Spies, and P. F. Barnes. 2005. Role of NK cellactivating receptors and their ligands in the lysis of mononuclear phagocytes infected with an intracellular bacterium. J. Immunol. 175: 4611-4617.
27. Weiss, I. D., O. Wald, H. Wald, K. Beider, M. Abraham, E. Galun, A. Nagler, and A. Peled. 2010. IFN-gamma treatment at early stages of influenza virus infection protects mice from death in a NK cell-dependent manner. J. Interferon Cytokine Res. 30: 439-449.
28. Lodoen, M. B., and L. L. Lanier. 2006. Natural killer cells as an initial defense against pathogens. Curr. Opin. Immunol. 18: 391-398.
29. Small, C. L., S. McCormick, N. Gill, K. Kugathasan, M. Santosuosso, N. Donaldson, D. E. Heinrichs, A. Ashkar, and Z. Xing. 2008. NK cells play a critical protective role in host defense against acute extracellular Staphylococcus aureus bacterial infection in the lung. J. Immunol. 180: 5558-5568.
30. Borchers, M. T., N. L. Harris, S. C. Wesselkamper, S. Zhang, Y. Chen, L. Young, and G. W. Lau. 2006. The NKG2D-activating receptor mediates pulmonary clearance of Pseudomonas aeruginosa. Infect. Immun. 74: 2578-2586.
31. Wesselkamper, S. C., B. L. Eppert, G. T. Motz, G. W. Lau, D. J. Hassett, and M. T. Borchers. 2008. NKG2D is critical for NK cell activation in host defense against Pseudomonas aeruginosa respiratory infection. J. Immunol. 181: 5481-5489.
32. Hall, L. J., C. T. Murphy, G. Hurley, A. Quinlan, F. Shanahan, K. Nally, and S. Melgar. 2013. Natural killer cells protect against mucosal and systemic infection with the enteric pathogen Citrobacter rodentium. Infect. Immun. 81: 460-469.
33. + cells aid in the early induction of a Th1 response to an attaching and effacing enteric pathogen. Eur. J. Immunol. 43: 2638-2649.
34. Small, C. L., C. R. Shaler, S. McCormick, M. Jeyanathan, D. Damjanovic, E. G. Brown, P. Arck, M. Jordana, C. Kaushic, A. A. Ashkar, and Z. Xing. 2010. Influenza infection leads to increased susceptibility to subsequent bacterial superinfection by impairing NK cell responses in the lung. J. Immunol. 184: 2048-2056.
35. Kupz, A., T. A. Scott, G. T. Belz, D. M. Andrews, M. Greyer, A. M. Lew, A. G. Brooks, M. J. Smyth, R. Curtiss, III, S. Bedoui, and R. A. Strugnell. 2013. Contribution of Thy1+ NK cells to protective IFN-γ production during Salmonella typhimurium infections. Proc. Natl. Acad. Sci. USA 110: 2252-2257.
36. Vivier, E., D. H. Raulet, A. Moretta, M. A. Caligiuri, L. Zitvogel, L. L. Lanier, W. M. Yokoyama, and S. Ugolini. 2011. Innate or adaptive immunity? The example of natural killer cells. Science 331: 44-49.
37. Horowitz, A., K. A. Stegmann, and E. M. Riley. 2011. Activation of natural killer cells during microbial infections. Front. Immunol. 2: 88.
38. Scott, M. J., J. J. Hoth, S. A. Gardner, J. C. Peyton, and W. G. Cheadle. 2003. Natural killer cell activation primes macrophages to clear bacterial infection. Am. Surg. 69: 679-686, discussion 686-687.
39. Tsai, W. C., R. M. Strieter, J. M. Wilkowski, K. A. Bucknell, M. D. Burdick, S. A. Lira, and T. J. Standiford. 1998. Lung-specific transgenic expression of KC enhances resistance to Klebsiella pneumoniae in mice. J. Immunol. 161: 2435-2440.
40. Yoshida, K., T. Matsumoto, K. Tateda, K. Uchida, S. Tsujimoto, Y. Iwakurai, and K. Yamaguchi. 2001. Protection against pulmonary infection with Klebsiella pneumoniae in mice by interferon-gamma through activation of phagocytic cells and stimulation of production of other cytokines. J. Med. Microbiol. 50: 959-964.
41. Ruan, S., E. Young, M. J. Luce, J. Reiser, J. K. Kolls, and J. E. Shellito. 2006. Conditional expression of interferon-gamma to enhance host responses to pulmonary bacterial infection. Pulm. Pharmacol. Ther. 19: 251-257.
42. Moore, T. A., M. L. Perry, A. G. Getsoian, M. W. Newstead, and T. J. Standiford. 2002. Divergent role of gamma interferon in a murine model of pulmonary versus systemic Klebsiella pneumoniae infection. Infect. Immun. 70: 6310-6318.
43. Laichalk, L. L., S. L. Kunkel, R. M. Strieter, J. M. Danforth, M. B. Bailie, and T. J. Standiford. 1996. Tumor necrosis factor mediates lung antibacterial host defense in murine Klebsiella pneumonia. Infect. Immun. 64: 5211-5218.
44. Sutherland, R. E., J. S. Olsen, A. McKinstry, S. A. Villalta, and P. J. Wolters. 2008. Mast cell IL-6 improves survival from Klebsiella pneumonia and sepsis by enhancing neutrophil killing. J. Immunol. 181: 5598-5605.
45. Huntington, N. D., H. Tabarias, K. Fairfax, J. Brady, Y. Hayakawa, M. A. Degli-Esposti, M. J. Smyth, D. M. Tarlinton, and S. L. Nutt. 2007. NK cell maturation and peripheral homeostasis is associated with KLRG1 up-regulation. J. Immunol. 178: 4764-4770.
46. Sun, J. C., J. N. Beilke, and L. L. Lanier. 2009. Adaptive immune features of natural killer cells. Nature 457: 557-561.
47. Le-Barillec, K., J. G. Magalhaes, E. Corcuff, A. Thuizat, P. J. Sansonetti, A. Phalipon, and J. P. Di Santo. 2005. Roles for T and NK cells in the innate immune response to Shigella flexneri. J. Immunol. 175: 1735-1740.
48. Grundy, M. A., and C. L. Sentman. 2006. Immunodeficient mice have elevated numbers of NK cells in non-lymphoid tissues. Exp. Cell Res. 312: 3920-3926.
49. Wolk, K., S. Kunz, E. Witte, M. Friedrich, K. Asadullah, and R. Sabat. 2004. IL-22 increases the innate immunity of tissues. Immunity 21: 241-254.
50. Liang, S. C., X. Y. Tan, D. P. Luxenberg, R. Karim, K. Dunussi-Joannopoulos, M. Collins, and L. A. Fouser. 2006. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med. 203: 2271-2279.
51. Liang, S. C., C. Nickerson-Nutter, D. D. Pittman, Y. Carrier, D. G. Goodwin, K. M. Shields, A. J. Lambert, S. H. Schelling, Q. G. Medley, H. L. Ma, et al. 2010. IL-22 induces an acute-phase response. J. Immunol. 185: 5531-5538.
52. Rutz, S., C. Eidenschenk, and W. Ouyang. 2013. IL-22, not simply a Th17 cytokine. Immunol. Rev. 252: 116-132.
53. Sonnenberg, G. F., L. A. Fouser, and D. Artis. 2011. Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nat. Immunol. 12: 383-390.
54. Sonnenberg, G. F., L. A. Monticelli, T. Alenghat, T. C. Fung, N. A. Hutnick, J. Kunisawa, N. Shibata, S. Grunberg, R. Sinha, A. M. Zahm, et al. 2012. Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria. Science 336: 1321-1325.
55. Wiltrout, R. H., A. Santoni, E. S. Peterson, D. C. Knott, W. R. Overton, R. B. Herberman, and H. T. Holden. 1985. Reactivity of anti-asialo GM1 serum with tumoricidal and non-tumoricidal mouse macrophages. J. Leukoc. Biol. 37: 597-614.
56. Lee, U., K. Santa, S. Habu, and T. Nishimura. 1996. Murine asialo GM1+CD8+ T cells as novel interleukin-12-responsive killer T cell precursors. Jpn. J. Cancer Res. 87: 429-432.
57. Nishikado, H., K. Mukai, Y. Kawano, Y. Minegishi, and H. Karasuyama. 2011. NK cell-depleting anti-asialo GM1 antibody exhibits a lethal off-target effect on basophils in vivo. J. Immunol. 186: 5766-5771.
58. Schmitt, D. M., D. M. O'Dee, M. J. Brown, J. Horzempa, B. C. Russo, P. A. Morel, and G. J. Nau. 2013. Role of NK cells in host defense against pulmonary type A Francisella tularensis infection. Microbes Infect. 15: 201-211.
59. Hall, L. J., S. Clare, and G. Dougan. 2010. NK cells influence both innate and adaptive immune responses after mucosal immunization with antigen and mucosal adjuvant. J. Immunol. 184: 4327-4337.
60. Ouyang, W., S. Rutz, N. K. Crellin, P. A. Valdez, and S. G. Hymowitz. 2011. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu. Rev. Immunol. 29: 71-109.
61. Eyerich, S., K. Eyerich, D. Pennino, T. Carbone, F. Nasorri, S. Pallotta, F. Cianfarani, T. Odorisio, C. Traidl-Hoffmann, H. Behrendt, et al. 2009. Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J. Clin. Invest. 119: 3573-3585.
62. Guilloteau, K., I. Paris, N. Pedretti, K. Boniface, F. Juchaux, V. Huguier, G. Guillet, F. X. Bernard, J. C. Lecron, and F. Morel. 2010. Skin Inflammation Induced by the Synergistic Action of IL-17A, IL-22, Oncostatin M, IL-1alpha, and TNF-alpha Recapitulates Some Features of Psoriasis. J. Immunol. 184: 5263-5270.
63. López, M. C., N. S. Duckett, S. D. Baron, and D. W. Metzger. 2004. Early activation of NK cells after lung infection with the intracellular bacterium, Francisella tularensis LVS. Cell. Immunol. 232: 75-85.
64. Byrne, P., P. McGuirk, S. Todryk, and K. H. Mills. 2004. Depletion of NK cells results in disseminating lethal infection with Bordetella pertussis associated with a reduction of antigen-specific Th1 and enhancement of Th2, but not Tr1 cells. Eur. J. Immunol. 34: 2579-2588.
65. Paget, C., S. Ivanov, J. Fontaine, J. Renneson, F. Blanc, M. Pichavant, L. Dumoutier, B. Ryffel, J. C. Renauld, P. Gosset, et al. 2012. Interleukin-22 is produced by invariant natural killer T lymphocytes during influenza A virus infection: potential role in protection against lung epithelial damages. J. Biol. Chem. 287: 8816-8829.
66. Guo, H., and D. J. Topham. 2010. Interleukin-22 (IL-22) production by pulmonary Natural Killer cells and the potential role of IL-22 during primary influenza virus infection. J. Virol. 84: 7750-7759.
67. Ivanov, S., J. Renneson, J. Fontaine, A. Barthelemy, C. Paget, E. M. Fernandez, F. Blanc, C. De Trez, L. Van Maele, L. Dumoutier, et al. 2013. Interleukin-22 reduces lung inflammation during influenza A virus infection and protects against secondary bacterial infection. J. Virol. 87: 6911-6924.
68. Culley, F. J. 2009. Natural killer cells in infection and inflammation of the lung. Immunology 128: 151-163.
69. Gibbert, K., J. J. Joedicke, A. Meryk, M. Trilling, S. Francois, J. Duppach, A. Kraft, K. S. Lang, and U. Dittmer. 2012. Interferon-alpha subtype 11 activates NK cells and enables control of retroviral infection. PLoS Pathog. 8: e1002868.
70. Inoue, S., J. Unsinger, C. G. Davis, J. T. Muenzer, T. A. Ferguson, K. Chang, D. F. Osborne, A. T. Clark, C. M. Coopersmith, J. E. McDunn, and R. S. Hotchkiss. 2010. IL-15 prevents apoptosis, reverses innate and adaptive immune dysfunction, and improves survival in sepsis. J. Immunol. 184: 1401-1409.